Startups
Your CDMO - From Benchtop R&D to Production Offering cGMP Pharmaceutical & Specialty Chemical Synthesis and Analytical Services in Multiple Markets Raybow USA, a Jiuzhou Pharma subsidiary, is a trusted chemical CDMO specializing in custom organic synthesis, process development, analytical services, and cGMP production for small molecules, specialty chemicals, and polymers.Bridge discovery to supply with
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 13, 2024 | Jiuzhou Pharma Appoints Industry Leader Mike Pennington as Global Head of TIDES | Dr. Mike Pennington, Global Head of Peptides and Oligonucleotides, Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Global Plans for Peptide and Conjugate Drug Processes He has both the leadership experience and technical background to be immediat... |
| Sep 21, 2022 | Privileged Chiral Spiro Ligands and Applications to Commercially Marketed APls | Raybow PharmaScience Logo These privileged chiral spiro ligands can be applied to a number of chemical transformations including asymmetric hydrogenation, asymmetric carbonyl reductions, cross-coupling (C-C, C-N, C-B), hydroboration/diborat... |
Reviews 0
FAQ about Raybow USA, Inc.
What has the press written about Raybow USA, Inc.?
Parsers VC has collected 3 articles mentioning Raybow USA, Inc., among them “Jiuzhou Pharma Appoints Industry Leader Mike Pennington as Global Head of TIDES” (Jun 13, 2024) and “Privileged Chiral Spiro Ligands and Applications to Commercially Marketed APls” (Sep 21, 2022).
Is Raybow USA, Inc. still active?
Yes, Raybow USA, Inc. is active; its latest activity on Parsers VC dates from Jul 22, 2026.